Basophil Granulocytes are a type of white blood cell that plays a crucial role in the immune system's response to allergens and parasitic infections. These granulocytes are characterized by the presence of large, dark-staining granules in their cytoplasm and are part of the innate immune system. Basophils release various mediators, including histamine and heparin, upon activation. Histamine is involved in the inflammatory response and contributes to symptoms such as itching and swelling in allergic reactions. Heparin functions as an anticoagulant, preventing blood clotting and promoting blood flow. Despite being a minority among white blood cells, basophils are strategically located in tissues and blood vessels, allowing them to quickly respond to invading pathogens or allergens. They express high-affinity IgE receptors, which bind to antibodies and facilitate the recognition of allergens. Elevated basophil counts can occur in certain allergic or parasitic conditions, providing clinicians with diagnostic information. Basophils also interact with other immune cells, contributing to the overall immune response. Research on basophil granulocytes is essential for understanding immune system regulation, allergic responses, and inflammatory processes. Targeting basophil function is explored in the development of therapies for allergic diseases and conditions associated with aberrant immune responses.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States